- Filed
- Mar 11, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 4, 2025 | 51.65M sh |
| Long Term Debt | Q3 2025 · Jan 31, 2025 | $397.54M |
| Long Term Debt | Q3 2025 · Apr 30, 2024 | $396.95M |
| Cash And Equivalents | Q3 2025 · Jan 31, 2025 | $779.3M |
| Cash And Equivalents | Q3 2025 · Apr 30, 2024 | $941.01M |
| Stockholders Equity | Q3 2025 · Jan 31, 2025 | $1.79B |
| Stockholders Equity | Q3 2025 · Apr 30, 2024 | $1.73B |
| Current Liabilities | Q3 2025 · Jan 31, 2025 | $817.76M |
| Current Liabilities | Q3 2025 · Apr 30, 2024 | $934.52M |
| Total Liabilities | Q3 2025 · Jan 31, 2025 | $1.85B |
| Total Liabilities | Q3 2025 · Apr 30, 2024 | $1.94B |
| Current Assets | Q3 2025 · Jan 31, 2025 | $1.56B |
| Current Assets | Q3 2025 · Apr 30, 2024 | $1.67B |
| Total Assets | Q3 2025 · Jan 31, 2025 | $3.65B |
| Total Assets | Q3 2025 · Apr 30, 2024 | $3.68B |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 51.34M sh |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 51.33M sh |
| Stock Repurchased | Q3 2025 · Jan 31, 2024 | $30.13M |
| Dividends Paid | Q3 2025 · Jan 31, 2024 | $36.91M |
| Capex | Q3 2025 · Jan 31, 2024 | $43.29M |
| Operating Cash Flow | Q3 2025 · Jan 31, 2024 | $22.11M |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | $1.13 |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | $1.99 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | $1.14 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | $2.00 |
| Sga Expense | Q3 2025 · Jan 31, 2024 | $62.66M |
| Sga Expense | Q3 2025 · Jan 31, 2024 | $194.32M |
| Net Income | Q3 2025 · Jan 31, 2024 | $59.07M |
| Net Income | Q3 2025 · Jan 31, 2024 | $103.97M |
| Operating Income | Q3 2025 · Jan 31, 2024 | $49.87M |
| Operating Income | Q3 2025 · Jan 31, 2024 | $129.45M |
| Revenue | Q3 2025 · Jan 31, 2024 | $676.87M |
| Revenue | Q3 2025 · Jan 31, 2024 | $2.1B |